NECTIN2 and breast ductal adenocarcinoma: Nectin-2 was reduced in tumors with positive lymph nodes and metastasis, increasing NPI and tumor grade. The expression was elevated with higher TNM (I vs. III), ER tumors and in ductal carcinoma. Patients who died from the disease had reduced expression of nectin-2. High-expressing patients had longer mean survival.